Summary
The effects of bucumolol (BUC), nadolol (NAD) and nifenalol (NIF) on contractile forces and on action potentials (APs) were investigated in isolated guinea pig atrial and papillary muscles, respectively. Log 1/ED40 values for the negative inotropic effects of these drugs were 0.097,10 and 0.74 mmol/l in this order. BUC (50 μmol/l), NAD (0.5 mmol/l) and NIF (0.2 mmol/l) produced about 60,20 and 20% reduction of V max at 1 Hz. The frequency-dependent reductions at these and higher concentrations were greatest for BUC, intermediate for NAD and least for NIF. These potencies at certain frequencies were, as a whole, consistent with log P-potency relationship established in our previous papers (Harada et al. 1981; Ban et al. 1985). The reductions of V max in APs in response to premature stimuli during basic stimuli at the rate of 0.25 or 0.027 Hz decayed exponentially during diastolic intervals (DI). The time constants of these decay processes (τ) estimated by linear and nonlinear regression analyses and by eye were 12.2–9.6 s for BUC (50–100 μmol/l) and 2.9–4.8 s for NAD (1–2 mmol/l) and 57–87 ms for NIF (0.2–1 mmol/l). In terms of the molecular weight (MW)-log τ relationship (Ban et al. 1985), these τ values are within the 95% fiducial limit for BUC and NAD and deviated from the lower fiducial limit for NIF. The frequency-dependent reductions of V max by these drugs were explained in terms of a function of τ and the intercept Ao. Based on the study mady by Cohen et al. (1984) we estimated the distortion of the time course of recovery of V max from that of sodium channel availability in the presence of drugs. Our computation shows that the relative change of the τ estimated at the same level of the zero-intercept does, but that of the τ estimated at different levels does not, reflext exactly that of the time constants of the recovery of sodium channel availability.
Similar content being viewed by others
References
Ban T, Sada S, Takahashi Y, Sada H, Fujita T (1985) Effects of para-substituted beta-adrenoceptor blocking agents and methyl-substituted phenoxypropanolamine derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles. Naunyn-Schmiedeberg's Arch Pharmacol 329:77–85
Campbell TJ (1983) Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractiriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc Res 17:344–352
Campbell TJ, Vaughan Williams EM (1983) Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new anti-arrhythmic drugs, flecainide and lorcainide. Cardiovasc Res 17:251–258
Cohen CJ, Bean BP, Tsien RW (1984) Maximal upstroke velocity as an index of available sodium conductance. Comparison of maximal upstroke velocity and voltage clamp measurements of sodium current in rabbit Purkinje fibers. Circ Res 54:636–651
Courtney KR (1984) Relationship between excitability block and negative inotropic actions of antiarrhythmic drugs. Proc West Pharmacol Soc 27:181–184
Cruickshank JM (1980) The clinical importance of cardioselectivity and lipophilicity in beta blockers. Am Heart J 100:160–178
DiFrancesco D, Noble D (1985) A model of cardiac electrical activity incorporating ionic pumps and concentration changes. Philos Trans R Soc Lond [Biol] B 307:353–398
Ebner F, Reiter M (1979) The influence of (+)-propranolol on the inotropic effect of dihydro-ouabain in relation to stimulation frequency. Naunyn-Schmiedeberg's Arch Pharmacol 307: 105–113
Eisner DA, Lederer WJ, Sheu S-S (1983) The role of intracellular sodium activity in the anti-arrhythmic action of local anaesthetics in sheep Purkinje fibres. J Physiol 340:239–257
Evans DB, Parham CS, Laffan RJ (1979) Non-specific myocardial depression by beta-adrenergic receptor blockers in normal and compromised myocardium. Arch Int Pharmacodyn Ther 240:240–248
Fozzard HA, Wasserstrom AJ (1985) Voltage dependence of intracellular sodium and control of contraction. In: Zipes DP, Jalife J (eds) Cardiac electrophysiology and arrhythmias. Grune and Stratton, Orlando, pp 51–57
Gibson JK, Gelband H, Bassett AL (1977) Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium. J Pharmacol Exp Ther 202:702–710
Grant AO, Starmer CF, Strauss HC (1984) Antiarrhythmic drug action: blockade of the inward sodium current. Cir Res 55:427–439
Hansch C, Leo A (1979) Substituent constants for correlation analysis in chemistry and biology, Wiley-Interscience, New York
Harada S, Ban T, Fujita T, Koshiro A (1981) Negative inotropic effects and the hydrophobicity of beta-adrenergic blocking agents. Arch Int Pharmacodyn Ther 252:262–271
Hellenbrecht D, Müller K-F, Grobecker H (1974) Prediction of the non-specific cardiodepressant effects of β-adrenoceptor blocking agents in vitro and in vivo by means of the Hansch analysis. Eur J Pharmacol 29:223–235
Hellenbrecht D, Enenkel J (1984) Estimation of the nonspecific cardiovascular toxicity of β-adrenoceptor blocking drugs with different hydrophobic properties in the cat. Arzneim-Forsch/Drug Res 34:980–983
Hondeghem LM, Katzung BG (1977) Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 472:373–398
Hondeghem LM, Katzung BG (1984) Antiarrhythmic agents: The modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Ann Rev Pharmacol Toxicol 24: 387–423
Keefe D, Kates R, Harrison (1981) New antiarrhythmic drugs: their place in therapy. Drugs 22:363–400
Lee RJ, Evans DB, Baky SH, Laffan RJ (1975) Pharmacology of nadolol (SQ 11725), a β-adrenergic antagonist lacking direct myocardial depression. Eur J Pharmacol 33:371–382
Levy JV (1968) Myocardial and local anesthetic action of β-adrenergic receptor blocking drugs: relationships to physico-chemical properties. Eur J Pharmacol 2:250–257
Lüllmann H, Timmermans PBMWM, Ziegler A (1979) Accumulation of drugs by resting or beating cardiac tissue. Eur J Pharmacol 60:277–285
Nishimura K, Omatsu M, Fujita T (1985) Physicochemical properties of pyrethroids and specific action-potential changes. Neuro Toxicology 6:117–126
Oshima T, Kumakura S, Koike H, Nakayama K (1973) Pharmacology of d1-5-methyl-8-(2-hydroxy-3-t-butylaminopropoxy) coumarin hydrochloride (CS-359), a new β-adrenergic blocking agent. Jpn J Pharmacol 23:497–513
Ohhita S, Sada H, Kojima M, Ban T (1980) Effects of tocainide and lidocaine on the transmembrane action potentials as related to external potassium and calcium concentrations in guinea-pig papillary muscles. Naunyn-Schmiedeberg's Arch Pharmacol 314:67–82
Rodenkirchen R, Bayer R, Mannhold R (1982) II. Specific and non-specific Ca antagonists. A structure-activity analysis of cardiodepressive drugs. Prog Pharmacol 5:9–23
Sada H, Ban T (1981) Effects of various structurally related beta-adrenoceptor blocking agents on maximum upstroke velocity of action potential in guinca-pig papillary muscles. Naunyn-Schmiedeberg's Arch Pharmacol 317:245–251
Sada H, Harada S, Ban T (1983) Effects of beta-adrenoceptor blocking agents of N-tertiary butyl derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles. Naunyn-Schmiedeberg's Arch Pharmacol 324:50–57
Sada H (1978) Effect of phetolamine, alprenolol and prenylamine on maximum rate of rise of action potential in guinea-pig papillary muscles. Naunyn-Schmiedeberg's Arch Pharmacol 304:191–201
Sada H, Kojima M, Ban T (1979) Effect of procainamide on transmembrane action potentials in guinea-pig papillary muscles as affected by external potassium concentration. Naunyn-Schmiedeberg's Arch Pharmacol 309:179–190
Singh BN, Vaughan Williams EM (1971) Effects on cardiac muscle of the β-adrenoceptor blocking drugs INPEA and LB46 in relation to their local anaesthetic action on nerve. Br J Pharmacol 43:10–22
Vaughan Williams EM, Campbell TJ (1982) The effects of nadolol on various cardiac tissues in normoxia, and on atrial muscle in simulated ischaemia. Eur J Pharmacol 83:161–169
Wood JJ (1984) Pharmacologic differences between beta blockers. Am Heart J 108:1070–1077
Yamaoka K, Tanigawara Y (1983) Yakubutsu-sokudoron-nyumon (Introduction to Pharmacokinetics) (Japanese). Nankodo, Tokyo
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ichiyama, M., Sada, S., Takahashi, Y. et al. Effects of bucumolol, nadolol and nifenalol on maximum upstroke velocity of action potential in guinea pig papillary muscles. Naunyn-Schmiedeberg's Arch. Pharmacol. 332, 297–304 (1986). https://doi.org/10.1007/BF00504871
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00504871